Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

Ver Toda la documentación

T-021

Supelco

Trinitroglycerin solution

1 % (w/w) in propylene glycol, ampule of 1 mL, certified reference material, Cerilliant®

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula empírica (notación de Hill):
C3H5N3O9
Número de CAS:
55-63-0
Peso molecular:
227.09
Número MDL:
MFCD00171649
Código UNSPSC:
41116107
ID de la sustancia en PubChem:
329826592
NACRES:
NA.24

grado

certified reference material

Nivel de calidad

300

Formulario

liquid

Características

Snap-N-Spike®/Snap-N-Shoot®

envase

ampule of 1 mL

fabricante / nombre comercial

Cerilliant®

concentración

1 % (w/w) in propylene glycol

técnicas

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

aplicaciones

pharmaceutical (small molecule)

Formato

single component solution

temp. de almacenamiento

−20°C

cadena SMILES

O=[N+]([O-])OCC(CO[N+]([O-])=O)O[N+]([O-])=O

InChI

1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2

Clave InChI

SNIOPGDIGTZGOP-UHFFFAOYSA-N

Información sobre el gen

human ... GUCY1A1(2982) , GUCY1A2(2977) , GUCY1B1(2983) , GUCY1B2(2974)

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Descripción general

Trinitroglycerin, also commonly known as nitroglycerin, is a pharmaceutical vasodilator used to treat heart conditions such as angina and chronic heart failure. This explosive compound is also an ingredient in dynamite and gunpowder. This Certified Spiking Solution® is suitable for use in chromatography or mass spectrometry-based applications in pharmaceutical research or clinical toxicology.

Información legal

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Producto relacionado

Referencia del producto
Descripción
Precios

D-002

1,2-Dinitroglycerin solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

D-003

1,3-Dinitroglycerin solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

D-010

1,2-Dinitroglycerin solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

D-011

1,3-Dinitroglycerin solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

M-001

1-Mononitroglycerin solution, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

M-077

1-Mononitroglycerin solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

M-078

2-Mononitroglycerin solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

T-002

Trinitroglycerin solution, 1000 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

Pictogramas

FlameSkull and crossbones
GHS02,GHS06

Palabra de señalización

Danger

Frases de peligro

H225,H302,H311

Clasificaciones de peligro

Acute Tox. 3 Dermal - Acute Tox. 4 Oral - Flam. Liq. 2

Código de clase de almacenamiento

3 - Flammable liquids

Clase de riesgo para el agua (WGK)

WGK 2

Punto de inflamabilidad (°F)

51.8 °F - closed cup

Punto de inflamabilidad (°C)

11 °C - closed cup

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Slide 1 of 2

1 of 2

Carboxy-PTIO potassium salt

Sigma-Aldrich

C221

Carboxy-PTIO potassium salt

Rapamycin from Streptomyces hygroscopicus ≥95% (HPLC), powder

Sigma-Aldrich

R0395

Rapamycin from Streptomyces hygroscopicus

Tatsuya Maruhashi et al.
Arteriosclerosis, thrombosis, and vascular biology, 33(6), 1401-1408 (2013-03-23)
Nitroglycerine-induced vasodilation has been used as a control test for flow-mediated vasodilation (FMD) to differentiate endothelium-dependent from endothelium-independent response when evaluating endothelial function in humans. Recently, nitroglycerine-induced vasodilation has also been reported to be impaired in patients with atherosclerosis. The
Chie Matsuda et al.
Masui. The Japanese journal of anesthesiology, 62(4), 390-394 (2013-05-24)
Rapid and transient uterine relaxation is sometimes required for fetal distress or difficult delivery due to uterine hyperactivity during cesarean section. For its rapid onset and short duration, intravenous nitroglycerin (NTG) is commonly used for this purpose. But its suitable
Kate Kleydman et al.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 38(12), 1889-1897 (2012-12-05)
Skin necrosis after soft tissue augmentation with dermal fillers is a rare but potentially severe complication. Nitroglycerin paste may be an important treatment option for dermal and epidermal ischemia in cosmetic surgery. To summarize the knowledge about nitroglycerin paste in
Hosein Kimiaei Asadi et al.
Acta cirurgica brasileira, 28(1), 19-25 (2013-01-23)
To evaluate the effect of nitroglycerine (NTG) on sensory and motor block onset and recovery time as well as the quality of tourniquet pain relief, when added to lidocaine (LID) for intravenous regional anesthesia in elective forearm and hand surgery.
Yuichi Fujii et al.
Circulation journal : official journal of the Japanese Circulation Society, 77(4), 1073-1080 (2012-12-12)
The purpose of this study was to evaluate the effect of anatomical variation of the brachial artery on flow-mediated vasodilation (FMD) in healthy subjects and patients with cardiovascular disease (CVD). There was no significant difference in the prevalence of double
Ver todos los artículos relacionados

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico